Singular Genomics

Singular Genomics

Biotechnology Research

San Diego, California 33,505 followers

Accelerating multiomics for the advancement of science and medicine.

About us

Singular Genomics is driving innovation at the forefront of multiomics. Dedicated to supporting the scientific community, we focus on creating scientific advancements influenced by real-world feedback and solution-oriented development. As a publicly-traded life science technology company, we specialize in advanced next-generation sequencing (NGS) and multiomic technologies, developing products that empower researchers and clinicians. The G4 Sequencing Platform, our first commercially available product, is an innovative benchtop sequencer featuring a novel 4-color rapid sequencing-by-synthesis (SBS) chemistry and advanced engineering, providing single-day turnaround times for various applications. Our recently launched G4X Spatial Sequencer, which is an upgrade to the G4 Sequencing Platform, is designed to offer high throughput in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues. We are committed to unlocking the potential of our core technologies to reshape the future of multiomics. We offer a dynamic, fast-paced, results-oriented environment where employees can make a significant impact. Innovation, continuous learning, multi-disciplinary collaboration, and diversity of thought are pillars of our culture.

Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
San Diego, California
Type
Public Company
Founded
2016
Specialties
Biotechnology, Genomics, Research, and Sequencing

Locations

Employees at Singular Genomics

Updates

Similar pages

Browse jobs

Funding

Singular Genomics 3 total rounds

Last Round

Convertible note

US$ 130.5M

See more info on crunchbase